Denali Therapeutics Inc. DNLI Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Denali Therapeutics Inc.'s preferred stock, shares outstanding?
- Denali Therapeutics Inc. (DNLI) reported preferred stock, shares outstanding of $0 in Q1 2026.